Methods of using chemiluminescent 1,2-dioxetanes

• US 4,931,223 A
• Filed: 06/30/1988
• Issued: 06/05/1990
• Est. Priority Date: 07/24/1986
• Status: Expired due to Term

• Current Assignee: Applied Biosystems LLC (Thermo Fisher Scientific Incorporated)
• Original Assignee: Tropix Incorporated (Thermo Fisher Scientific Incorporated)
• Inventors: Voyta, John C., Bronstein, Irena Y.
• Primary Examiner(s): Lee, Mary C.
• Assistant Examiner(s): SCALZO, CATHERINE KILBY
• Application Number:
  US07/213,344
• Time in Patent Office: 705 Days
• Field of Search: 252/700, 435/4, 435/5, 435/7, 436/537, 549/23, 549/332, 549/401, 549/404, 546/18, 560/117, 560/138, 568/326
• US Class Current: 252/700
• CPC Class Codes: C07C 2603/00 Systems containing at least three condensed rings
• CPC Class Codes: C07C 2603/74 Adamantanes
• CPC Class Codes: C07C 43/196 containing hydroxy or O-metal groups
• CPC Class Codes: C07C 69/00 Esters of carboxylic acids; Esters of carbonic or haloformic acids ortho esters, see the relevant groups, e.g. C07C43/32
• CPC Class Codes: C07D 321/00 Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
• CPC Class Codes: C07F 9/12 with hydroxyaryl compounds
• CPC Class Codes: C07F 9/65512 condensed with carbocyclic rings or carbocyclic ring systems
• CPC Class Codes: C07F 9/65742 non-condensed with carbocyclic rings or heterocyclic rings or ring systems
• CPC Class Codes: C07H 15/203 Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
• CPC Class Codes: C07H 15/26 Acyclic or carbocyclic radicals, substituted by hetero rings
• CPC Class Codes: C12Q 1/34 involving hydrolase
• CPC Class Codes: G01N 21/76 Chemiluminescence; Bioluminescence
• CPC Class Codes: G01N 33/533 with fluorescent label
• CPC Class Codes: G01N 33/535 with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
• CPC Class Codes: G01N 33/581 with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
• CPC Class Codes: G01N 33/582 with fluorescent label
• CPC Class Codes: G01N 33/76 Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
• CPC Class Codes: Y10S 435/968 High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
• CPC Class Codes: Y10S 435/973 Simultaneous determination of more than one analyte

Abstract

Processes are disclosed in which light of different wavelengths is simultaneously released from two or more enzymatically decomposable chemiluminescent 1,2-dioxetane compounds, said compounds being configured, by means of the inclusion of a different light emitting fluorophore in each of them, to each emit light of said different wavelengths, by decomposing each of said compounds by means of a different enzyme. Such processes can be used in multi-channel assays--immunoassays, chemical assays and nucleic acid probe assays--to detect the presence or determine the concentration of chemical or biological substances, and in multi-channel chemical/physical probe procedures for studying the microstructures of macromolecules.

Claims

1. A process in which light of different wavelengths is simultaneously released from two or more enzymatically, chemically or electrochemically decomposable chemiluminescent 1,2-dioxetane compounds, at least one of said 1,2-dioxetane compounds being an enzymatically decomposable 1,2-dioxetane compound, said 1,2-dioxetane compounds being configured, by means of the inclusion of a different light emitting fluorophore in each of said 1,2-dioxetane compounds, to each emit upon decomposition light of said different wavelengths, which comprises decomposing each of said 1,2-dioxetane compounds by means of one of two or more different enzyme, chemical or electrochemical decomposing means, each of said decomposing means being specific to one of said 1,2-dioxetane compounds, at least one of said decomposing means being an enzyme decomposing means.

2. The process of claim 1 in which each of said compounds is represented by the general formula:

##STR9## wherein R₁ represents hydrogen, or a bond which, together with the indicated bond between R₂ and the 4-carbon atom of the dioxetane ring, bonds a substituent represented by R₂ to the 4-carbon atom through a spiro linkage, or an organic substituent that does not interfere with the production of light and that satisfies the valence of the dioxetane ring carbon atom to which it is attached, or a light-emitting fluorophore-forming fluorescent chromophore group bonded to the dioxetane ring through a single bond or a spiro linkage, to which an enzymatically, chemically or electrochemically decomposable group is bonded, R₂ represents hydrogen, or a bond which, together with the indicated bond between R₁ and the 4-carbon atom of the dioxetane ring, bonds a substituent represented by R₁ to the 4-carbon atom through a spiro linkage, or a light-emitting fluorophore-forming fluorescent chromophore group bonded to the dioxetane ring through a single bond or a spiro linkage, to which an enzymatically, chemically or electrochemically decomposable group is bonded, at least one of R₁ and R₂ being such light-emitting fluorophore-forming fluorescent chromophore group, and T represents a stabilizing group that prevents the dioxetane compound from decomposing before the bond in the enzymatically, chemically or electrochemically decomposable group is intentionally cleaved.

3. The process of claim 2 in which the process carried out is a step in an immunoassay.

4. The process of claim 3 in which the immunoassay is for the detection of specific binding pairs comprising an antigen and an antibody.

5. The process of claim 3 in which the labels used in the assay are enzymes.

6. The process of claim 3 in which the labels used in the assay are the chemiluminescent 1,2-dioxetane compounds.

7. The process of claim 3 in which the immunoassay is for the detection of an enzyme.

8. The process of claim 3 in which the immunoassay is for the detection of hormones.

9. The process of claim 2 in which the process carried out is a step in a chemical assay.

10. The process of claim 9 in which the chemical assay is for the detection of chemical substances which, during the assay, are caused to decompose to form substances capable of causing the chemiluminescent 1,2-dioxetane compounds to decompose.

11. The process of claim 10 in which one of the chemical substances is glucose.

12. The process of claim 10 in which one of the chemical substances is cholesterol.

13. The process of claim 2 in which the process carried out is a nucleic acid probe assay.

14. The process of claim 13 in which the nucleic acid probe assay is for the detection of viruses.

15. The process of claim 2 in which the process carried out is a histocompatibility assay.

16. The process of claim 2 in which the process carried out is a technique for studying the microstructure of a macromolecule.

17. The process of claim 2 in which the process carried out is a multi-channel assay carried out in the presence of at least two of the chemiluminescent 1,2-dioxetane compounds as recited in claim 2 as substrates, each of which upon decomposition emits light of a different wavelength from the other(s).

18. The process of claim 17 in which at least one of said chemiluminescent 1,2-dioxetane compounds is chemically decomposable.

19. The process of claim 17 in which at least one of said chemilumenescent 1,2-dioxetane compounds is electrically decomposable.